|View printer-friendly version|
|Wright Medical Group, Inc. Introduces PROFEMUR Tapered Stem Total Hip System|
ARLINGTON, Tenn.--(BUSINESS WIRE)--Dec. 8, 2004--
New Tapered Stem Design Joins Wright's Family of Hip Implant Systems;
Ideally Suited for Minimally Invasive Surgical Approach
Wright Medical Group, Inc. (NASDAQ:WMGI), a global orthopaedic medical device company specializing in the design, manufacture and marketing of reconstructive joint devices and biologic materials, today announced the launch of its PROFEMUR(R) Tapered Stem Total Hip System. The new rounded, tapered stem design reduces the potential for implant loosening and thigh pain and requires the removal of less bone from within the femoral canal. The tapered stem feature complements the PROFEMUR(R) system's innovative modular neck design, which is specially suited for use with a smaller surgical incision.
The PROFEMUR(R) Tapered Stem Total Hip System is an integral part of Wright's ODYSSEY(sm) Tissue Preserving Initiative, a minimally invasive surgery program for hip, knee and total joint resurfacing procedures. Although many orthopaedic manufacturers and surgeons have developed minimally invasive techniques, Wright offers the only solution that includes an implant system with a design that specifically addresses the most common challenges associated with a minimally invasive approach. The PROFEMUR(R) Hip System's modular neck feature simplifies implant insertion and reduces the risk of soft-tissue damage. Wright's modular neck technology also offers surgeons unsurpassed flexibility in addressing a wide range of patient anatomies intraoperatively. Through the PROFEMUR(R) system's new tapered stem feature, the implant also provides improved stability and reduced procedure time.
"We have been working diligently to fill our modular neck stem portfolio to cover all existing philosophies in the marketplace," explains Aldo Denti, Vice President of Wright's OrthoRecon Division. "Wright is pleased to respond to U.S. surgeon demands for a rounded, tapered stem design, with the added benefits of PROFEMUR(R)'s progressive modular neck feature. For the many surgeons transitioning to a less invasive technique for hip arthroplasty, Wright offers the total package with the PROFEMUR(R) Tapered Stem."
The PROFEMUR(R) Tapered Stem Total Hip System represents the latest enhancement to Wright's family of innovative hip solutions featuring modular neck technology. The product family includes the PROFEMUR(R) Total Hip System, the PROFEMUR(R) E Hip Stem, the PROFEMUR(R) Z Hip Stem, the PROFEMUR(R) Plasma Z Hip Stem and the PROFEMUR(R) R Revision Prosthesis.
Wright Medical Group, Inc. is a global orthopaedic medical device company specializing in the design, manufacture and marketing of reconstructive joint devices and biologics. The Company has been in business for more than 50 years and markets its products in over 40 countries worldwide. For more information about Wright Medical, visit our website at www.wmt.com.
This press release may contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements made in this press release, other than statements of historical fact, are forward-looking statements. Forward-looking statements reflect management's current knowledge, assumptions, beliefs, estimates, and expectations and express management's current views of future performance, results, and trends. The Company wishes to caution readers that actual results might differ materially from those described in the forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties, including the factors discussed in the Company's filings with the Securities and Exchange Commission (including the Company's annual report on Form 10-K for the year ended December 31, 2003), which could cause the Company's actual results to materially differ from those described in the forward-looking statements. Although the Company believes that the forward-looking statements are accurate, there can be no assurance that any forward-looking statement will prove to be accurate. A forward-looking statement should not be regarded as a representation by the Company that the results described therein will be achieved. The Company wishes to caution readers not to place undue reliance on any forward-looking statement. The forward-looking statements are made as of the date of this press release. The Company assumes no obligation to update any forward-looking statement after this date.
CONTACT: Wright Medical Group, Inc. John K. Bakewell, 901-867-4527 www.wmt.com SOURCE: Wright Medical Group, Inc.